Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection

International Journal of Clinical Practice

Volumn 62, Issue 7, 2008, Pages 1056-1062

  Zhao, L ^a   Li, T ^a   Wang, Y ^b   Pan, Y ^a   Ning, H ^c   Hui, X ^a   Xie, H ^a   Wang, J ^a   Han, Y ^a   Liu, Z ^a   Fan, D ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Chinese PLA General Logistic Department   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; OSTEOPONTIN;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER RISK; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE;

ADULT; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OSTEOPONTIN; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 44849134814     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01368.x     Document Type: Article

References (49)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997 337 : 1733 45.
2. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003 362 : 2089 94.
3. Pol S. Natural history of hepatitis B infection. Presse Med 2006 35 : 308 16.
4. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002 97 : 2614 8.
5. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006 55 : 569 78.
6. Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology 2006 43 : S113 20.
7. Zhang H, Ye QH, Ren N et al. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2006 132 : 709 17.
8. Uede T, Katagiri Y, Iizuka J, Murakami M. Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein? Microbiol Immunol 1997 41 : 641 8.
9. Lorena D, Darby IA, Gadeau AP et al. Osteopontin expression in normal and fibrotic liver. altered liver healing in osteopontin-deficient mice. J Hepatol 2006 44 : 383 90.
10. Lee SH, Seo GS, Park YN, Yoo TM, Sohn DH. Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol 2004 68 : 2367 78.
11. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 2004 287 : G264 73.
12. Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 2002 52 : 19 24.
13. Ye QH, Qin LX, Forgues M et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003 9 : 416 23.
14. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973 60 : 646 9.
15. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003 38 : 518 26.
16. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J. Osteopontin - a molecule for all seasons. QJM 2002 95 : 3 13.
17. Denhardt DT, Giachelli CM, Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 2001 41 : 723 49.
18. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001 107 : 1055 61.
19. Isoda K, Nishikawa K, Kamezawa Y et al. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ Res 2002 91 : 77 82.
20. Chiba S, Okamoto H, Kon S et al. Development of atherosclerosis in osteopontin transgenic mice. Heart Vessels 2002 16 : 111 7.
21. O'Regan AW, Hayden JM, Body S et al. Abnormal pulmonary granuloma formation in osteopontin-deficient mice. Am J Respir Crit Care Med 2001 164 : 2243 7.
22. Chabas D, Baranzini SE, Mitchell D et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001 294 : 1731 5.
23. O'Regan A, Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 2000 81 : 373 90.
24. Yumoto K, Ishijima M, Rittling SR et al. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci U S A 2002 99 : 4556 61.
25. Yamamoto N, Sakai F, Kon S et al. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest 2003 112 : 181 8.
26. Caillier S, Barcellos LF, Baranzini SE et al. Osteopontin polymorphisms and disease course in multiple sclerosis. Genes Immun 2003 4 : 312 5.
27. Hanawa H, Abe S, Hayashi M et al. Time course of gene expression in rat experimental autoimmune myocarditis. Clin Sci (Lond) 2002 103 : 623 32.
28. Kawashima R, Mochida S, Matsui A et al. Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 1999 256 : 527 31.
29. Whitington PF, Malladi P, Melin-Aldana H, Azzam R, Mack CL, Sahai A. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr Res 2005 57 : 837 44.
30. Furger KA, Menon RK, Tuck AB, Bramwell VH, Chambers AF. The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med 2001 1 : 621 32.
31. Weber GF. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 2001 1552 : 61 85.
32. Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 2005 42 (Suppl. S22 36.
33. Pinzani M. Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched. Gut 2006 55 : 310 2.
34. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001 357 : 1069 75.
35. Patel K, Gordon SC, Jacobson I et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004 41 : 935 42.
36. Forns X, Ampurdanes S, Llovet JM et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002 36 : 986 92.
37. Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998 93 : 44 8.
38. Sud A, Hui JM, Farrell GC et al. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology 2004 39 : 1239 47.
39. Teare JP, Sherman D, Greenfield SM et al. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Lancet 1993 342 : 895 8.
40. Rosenberg WM, Voelker M, Thiel R et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004 127 : 1704 13.
41. Forootan SS, Foster CS, Aachi VR et al. Prognostic significance of osteopontin expression in human prostate cancer. Int J Cancer 2006 118 : 2255 61.
42. Carlinfante G, Vassiliou D, Svensson O, Wendel M, Heinegard D, Andersson G. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clin Exp Metastasis 2003 20 : 437 44.
43. Pan HW, Ou YH, Peng SY et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 2003 98 : 119 27.
44. Rudland PS, Platt-Higgins A, El-Tanani M et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res 2002 62 : 3417 27.
45. Agrawal D, Chen T, Irby R et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 2002 94 : 513 21.
46. Thalmann GN, Sikes RA, Devoll RE et al. Osteopontin: possible role in prostate cancer progression. Clin Cancer Res 1999 5 : 2271 7.
47. Tuck AB, O'Malley FP, Singhal H et al. Osteopontin expression in a group of lymph node negative breast cancer patients. Int J Cancer 1998 79 : 502 8.
48. Ue T, Yokozaki H, Kitadai Y et al. Co-expression of osteopontin and CD44v9 in gastric cancer. Int J Cancer 1998 79 : 127 32.
49. Chambers AF, Wilson SM, Kerkvliet N, O'Malley FP, Harris JF, Casson AG. Osteopontin expression in lung cancer. Lung Cancer 1996 15 : 311 23.